Acute atomoxetine treatment of younger and older children with ADHD: A meta-analysis of tolerability and efficacy

• Asıl Yazarlar: Vaughan Brigette S (Yazar), Milton Denái R (Yazar), Kratochvil Christopher J (Yazar), Greenhill Laurence L (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2008-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Atomoxetine is FDA-approved as a treatment of attention-deficit/hyperactivity disorder (ADHD) in patients aged 6 years to adult. Among pediatric clinical trials of atomoxetine to date, six with a randomized, double-blind, placebo-con...